Resources Contact Us Home
43 Kd protein vaccine and method for the production thereof

Image Number 3 for United States Patent #5543304.

A protein derivable from Actinobacillus pleuropneumoniae (APP) having a molecular size ranging between 43 Kd on SDS PAGE is described. The protein is soluble on sodium lauryl sarcosinate (SLS) and not heat modifiable. The protein can also be derived by recombinant methods. The protein in a vaccine provides immunity against multiple serotypes of APP.

  Recently Added Patents
Launch cable case
Evolutionary clustering algorithm
Account and customer creation in an on-line banking model
System and method for the heterologous expression of polyketide synthase gene clusters
Consistent retention and disposition of managed content and associated metadata
Image capture system and method
Information repository search system
  Randomly Featured Patents
Decorative stand for a shot glass in the shape of a rattlesnake head
Rubber plug with lips
Computer-mirrored panel input device
System and method for increasing distribution distance of XDSL type signals
Regenerative cyclone-type air/particulate concentrator and collector
Method of resetting a server
Envelope attachment for message context
Carbon dioxide monitoring of composites
(1,8) naphthyridines as gaba ligands, their pharmaceutical compositions and uses
Ergonomically accessible airflow control mechanism for a register